SCHEMBL3801904

SCHEMBL3801904

COc1cc2[nH]nnc2c(CCl)c1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3798339 0.85 PDE4A (0.32) —
SCHEMBL13160143 0.80 GRIN2D (0.34) —
SCHEMBL3799530 0.76 BRD4 (0.39) —
SCHEMBL3794387 0.71 MAPT (0.37) —
SCHEMBL17968324 0.67 MAPK10 (0.37) —
SCHEMBL9951542 0.67 GRIN2D (0.46) —
SCHEMBL2491037 0.66 — —
SCHEMBL13890392 0.65 AMY1A (0.39) —
SCHEMBL9497249 0.65 PDE10A (0.32) —
SCHEMBL9509223 0.65 ACHE (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010117425-A1 CERTAIN SUBSTITUTED PYRIMIDINES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR THEIR USE BIOGEN IDEC MA INC. (US) 2010-10-14 — — WO disclosed
Send feedback